Glitch For HLB/Hengrui’s Liver Cancer Combo After US CRL

Quick Resolution Of CMC Issues Expected

 
• By Jung Won Shin
rejection
HLB, Hengrui To Communicate With FDA, Refile As Soon As Possible • Source: Shutterstock

More from South Korea

More from Focus On Asia